Trends in Women’s Leadership of Oncology Clinical Trials
It has been widely reported that women are underrepresented in leadership positions within academic medicine. This study aimed to assess trends in women representation as principal investigators (PIs) in oncology clinical trials and to characterize trends in women’s leadership in such trials conduct...
Main Authors: | Ithai Waldhorn, Ayelet Dekel, Anna Morozov, Elisa Sardas Alon, Danielle Stave, Noam Ben Tsrooya, Shir Schlosser, Gal Markel, David Bomze, Tomer Meirson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.885275/full |
Similar Items
-
Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation
by: Tomer Meirson, et al.
Published: (2020-06-01) -
The No. 1 Ladies' Detective Agency /
by: Smith, Alexander McCall, 1948-, author
Published: (2003) -
A corpse in shining armour /
by: 407770 Peacock, Caro
Published: (2009) -
Editorial: Women in pharmacology of anti-cancer drugs: 2021
by: Elisa Giovannetti, et al.
Published: (2022-11-01) -
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
by: Tomer Meirson, et al.
Published: (2022-12-01)